30
Participants
Start Date
October 31, 2025
Primary Completion Date
October 31, 2026
Study Completion Date
October 31, 2027
Rocklatan eye drops will be instilled nightly in one eye diagnosed with glaucoma for up to 12 months.
The eye not selected as the study eye will be used for comparison so both eyes will be imaged with the study devices to assess blood flow changes.
Two optical coherence tomography (OCT) devices will be used to assess blood flow changes.
One OCT device is FDA-cleared while the other is still experimental. Both devices assess blood flow in different ways.
Casey Eye Institute - Oregon Health & Science University, Portland
Collaborators (1)
Alcon Research
INDUSTRY
Oregon Health and Science University
OTHER